Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PPDS in Ocular Hypertension or Open-Angle Glaucoma
NCT01481077Phase 2Completed
- Sponsor
- Mati Therapeutics
- Start
- Nov 2011
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Mati Therapeutics. Started Nov 2011; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01481077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481077.